Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Cervical Cancer Screening in Gynecological Practices in Germany
The outbreak of the coronavirus disease 2019 (COVID-19) is a major challenge for healthcare systems and impedes cancer screening programs worldwide. However, no research has been performed that analyzes the effects of the COVID-19 pandemic on the newly implemented German Cervical Cancer Screening (C...
Tallennettuna:
Päätekijät: | , , , , |
---|---|
Aineistotyyppi: | Artikkeli |
Kieli: | englanti |
Julkaistu: |
Philipps-Universität Marburg
2022
|
Aiheet: | |
Linkit: | PDF-kokoteksti |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|
Yhteenveto: | The outbreak of the coronavirus disease 2019 (COVID-19) is a major challenge for healthcare systems and impedes cancer screening programs worldwide. However, no research has been performed that analyzes the effects of the COVID-19 pandemic on the newly implemented German Cervical Cancer Screening (CCS) program. Here, we showed a severe clinically relevant decrease of patients receiving CCS in Germany between the pre-pandemic time period of 2018–2019 and the pandemic years of 2020–2021. Given that this sudden drop in number of CCS per practice is unlikely, our data suggest a dramatic number of underdiagnosed cervical precancer lesions that may lead to increased cervical cancer burden in the future. |
---|---|
Huomautukset: | Gefördert durch den Open-Access-Publikationsfonds der UB Marburg. |
Ulkoasu: | 7 Seiten |
DOI: | 10.3390/cancers14194820 |